Back
FibroGen Vs. Regulus Therapeutics Industry Stock Comparison
Sell
27
FGEN
FibroGen
Last Price:
1.13
Seasonality Move:
-2.91%
Sell
42
RGLS
Regulus Therapeutics
Last Price:
2.65
Seasonality Move:
-15.53%
Sell
27
FibroGen (FGEN)
is a Sell
Is FibroGen a Buy, Sell or Hold?
- The current FibroGen [FGEN] share price is $1.14. The Score for FGEN is 27, which is 46% below its historic median score of 50, and infers higher risk than normal.
- FGEN is currently trading in the 20-30% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Sell
42
Regulus Therapeutics (RGLS)
is a Sell
Is Regulus Therapeutics a Buy, Sell or Hold?
- The current Regulus Therapeutics [RGLS] share price is $2.65. The Score for RGLS is 42, which is 16% below its historic median score of 50, and infers higher risk than normal.
- RGLS is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
FGEN Stock Price Chart
RGLS Stock Price Chart
What is Regulus Therapeutics's stock price today?
-
The Regulus Therapeutics share price today is $2.65
Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and RGLS is experiencing selling pressure, which indicates risk of future bearish movement.
FGEN Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | -0.19 | Sell |
| Relative Strength Index (14 RSI): | 37.02 | Sell |
| Chaikin Money Flow: | -349515 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (1.01 - 1.67) | Sell |
| Bollinger Bands (100): | (0.87 - 2.11) | Sell |
RGLS Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 0.04 | Buy |
| Relative Strength Index (14 RSI): | 57.57 | Buy |
| Chaikin Money Flow: | -361399 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (2.3 - 2.72) | Buy |
| Bollinger Bands (100): | (1.22 - 2.4) | Buy |
FGEN Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 1.09 | Buy |
| 20-day SMA: | 1.21 | Sell |
| 50-day SMA: | 1.72 | Sell |
| 200-day SMA: | 1.22 | Sell |
| 8-day EMA: | 1.13 | Buy |
| 20-day EMA: | 1.28 | Sell |
| 50-day EMA: | 1.5 | Sell |
| 200-day EMA: | 3.22 | Sell |
RGLS Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 2.45 | Buy |
| 20-day SMA: | 2.48 | Buy |
| 50-day SMA: | 2.28 | Buy |
| 200-day SMA: | 1.6 | Buy |
| 8-day EMA: | 2.5 | Buy |
| 20-day EMA: | 2.46 | Buy |
| 50-day EMA: | 2.27 | Buy |
| 200-day EMA: | 1.77 | Buy |
FibroGen Earnings Growth & FGEN Earnings Dates
- Analysts estimate an earnings increase this quarter of $0.40 per share, a decrease next quarter of $0.00 per share, an increase this year of $1.41 per share, and an increase next year of $1.84 per share.
Regulus Therapeutics Earnings Growth & RGLS Earnings Dates
- Analysts estimate an earnings increase this quarter of $0.28 per share, a decrease next quarter of $0.02 per share, an increase this year of $1.06 per share, and a decrease next year of $0.02 per share.
FibroGen Technical Analysis
| Apr 22 | Apr 23 | Apr 24 | Apr 25 | Apr 26 | Apr 29 | Apr 30 | May 1 | May 2 | May 3 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Apr | May | |||||||||
| 22 | 23 | 24 | 25 | 26 | 29 | 30 | 01 | 02 | 03 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Regulus Therapeutics Technical Analysis
| Apr 22 | Apr 23 | Apr 24 | Apr 25 | Apr 26 | Apr 29 | Apr 30 | May 1 | May 2 | May 3 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Apr | May | |||||||||
| 22 | 23 | 24 | 25 | 26 | 29 | 30 | 01 | 02 | 03 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||